What now and what next? The new era of OSCE

被引:9
|
作者
Ali, Majid [1 ,2 ]
机构
[1] Umm Al Qura Univ, Coll Pharm, Mecca, Saudi Arabia
[2] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia
来源
PHARMACY EDUCATION | 2020年 / 20卷 / 02期
关键词
COVID-19; Pandemic; Lockdown; Online Assessment; OSCE;
D O I
10.46542/pe.2020.202.5658
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
The COVID-19 pandemic has impacted all walks of life including the education sector. The suspension of on-campus activities within universities in the last few months, in the middle of a semester, allowed pharmacy educators to capitalise on existing technology in teaching and assessment. Objective structured clinical exams (OSCEs) which usually require a face-to-face assessment of skills, posed a special challenge to educators in the health profession including pharmacy. Several teleconference programmes have been trialed to conduct online or virtual OSCEs. Lack of resources and human workforce compelled faculty to utilise MyDispense, a web-based community pharmacy simulation programme, for conducting web-based OSCEs. The students agreed that this was an overall better learning experience compared to the traditional face-to-face OSCE. There is a need for a robust evaluation of these alternate methods of OSCE in contrast with traditional face-to-face OSCE. The accumulation of more literature is expected to be seen that would highlight the feasibility of the online or virtual OSCE capitalising on advancements in technology. This coupled with the emerging role of tele-pharmacy, and less complicated skills needing to be assessed in pharmacy education compared to nursing and medication education, could this method of OSCE be the future of pharmacy education?
引用
收藏
页码:56 / 58
页数:3
相关论文
共 50 条
  • [21] FGFR inhibitors in cholangiocarcinoma: what's now and what's next?
    Saborowski, Anna
    Lehmann, Ulrich
    Vogel, Arndt
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [22] Tailored Supplemental Screening for Breast Cancer: What Now and What Next?
    Berg, Wendie A.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (02) : 390 - 399
  • [23] Precision Approaches to Pancreatic Cancer Therapy: What Now and What Next?
    Fergus Keane
    Wungki Park
    Eileen M. O’Reilly
    Current Treatment Options in Gastroenterology, 2022, 20 (3) : 406 - 428
  • [24] The G8 and global health - What now? What next?
    Labonte, R
    Schrecker, T
    CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE, 2006, 97 (01): : 35 - 38
  • [25] Ebstein anomaly review: what's now, what's next?
    Dearani, Joseph A.
    Mora, Bassem N.
    Nelson, Timothy J.
    Haile, Dawit T.
    O'Leary, Patrick W.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (10) : 1101 - 1109
  • [26] BIOMARKERS OF CFTR TRANSDUCTION: WHAT'S NOW, WHAT'S NEXT?
    Clancy, John P.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S51 - S53
  • [27] Research on sepsis biomarkers in the emergency department: What now, what next?
    Philippon, Anne-Laure
    Freund, Yonathan
    EMERGENCIAS, 2019, 31 (05): : 302 - 303
  • [28] Small Incision Lenticule Extraction (SMILE): What Now? What Next?
    Randleman, J. Bradley
    OPHTHALMOLOGY, 2020, 127 (08) : 1035 - 1036
  • [29] Debating Brexit: Why Now and What Next?
    Lennox, Rob
    Shepherd, Nick
    HISTORIC ENVIRONMENT-POLICY & PRACTICE, 2017, 8 (03): : 173 - 180
  • [30] MASS DEACIDIFICATION - NOW THAT IT IS A REALITY, WHAT NEXT
    FRIEDER, R
    IFLA JOURNAL-INTERNATIONAL FEDERATION OF LIBRARY ASSOCIATIONS, 1991, 17 (02): : 142 - 146